Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia

被引:105
作者
Kirikae, T
Hirata, M
Yamasu, H
Kirikae, F
Tamura, H
Kayama, F
Nakatsuka, K
Yokochi, T
Nakano, M
机构
[1] Jichi Med Sch, Dept Microbiol, Minami Kawachi, Tochigi 3290498, Japan
[2] Jichi Med Sch, Dept Environm Hlth, Minami Kawachi, Tochigi 3290498, Japan
[3] Iwate Med Univ, Sch Med, Dept Bacteriol, Morioka, Iwate 0208505, Japan
[4] Seikagaku Corp, Tokyo Res Inst, Tokyo 2070021, Japan
[5] Aichi Med Univ, Dept Immunol & Microbiol, Nagakute, Aichi 4801195, Japan
关键词
D O I
10.1128/IAI.66.5.1861-1868.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CAP18 tan 18-kDa cationic antimicrobial protein) is a granulocyte-derived protein that can bind lipopolysaccharide (LPS) and inhibit various activities of LPS in vitro. The present study examined the protective effect of a synthetic 27-amino-acid peptide (CAP18(109-135)) from the LPS-binding domain of CAP18 against antibiotic induced endotoxin shock, using highly LPS-sensitive D-(+)-galactosamine (D-GalN)-sensitized C3H/HeN mice. The antibiotic-induced endotoxin (CAZ-endotoxin) was prepared from the culture filtrate of Pseudomonas aeruginosa PAO1 exposed to ceftazidime (CAZ). Injection of CAP18(109-135) protected the mice injected with LPS or CAZ-endotoxin from death and lowered their tumor necrosis factor (TNF) levels in serum in a dose-dependent manner. Treatment with CAZ caused death of the D-GalN-sensitized P. aeruginosa PAO-infected mice within 48 h, while injection with CAP18(109-135) rescued the mice from death. In the mice rescued from death by injection with CAP18(109-135), endotoxin levels in plasma and TNF production by fiver tissues were decreased but the numbers of viable infecting bacteria in their blood were mot decreased significantly and remained at the levels in CAZ-treated mice. These results indicate that CAP18(109-135) is capable of preventing antibiotic-induced endotoxic shock in mice with septicemia and that the effect is due to its LPS-neutralizing activity rather than to its antibacterial activity.
引用
收藏
页码:1861 / 1868
页数:8
相关论文
共 46 条
[31]  
MARRA MN, 1992, J IMMUNOL, V148, P532
[32]   ENDOTOXINS AND DISEASE MECHANISMS [J].
MORRISON, DC ;
RYAN, JL .
ANNUAL REVIEW OF MEDICINE, 1987, 38 :417-432
[33]   Contribution of soluble endotoxin released from Gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice [J].
Morrison, DC ;
Bucklin, SE ;
Leeson, MC ;
Norimatsu, M .
JOURNAL OF ENDOTOXIN RESEARCH, 1996, 3 (03) :237-243
[34]   Endotoxin/antibiotics and Gram-negative sepsis [J].
Morrison, DC .
JOURNAL OF ENDOTOXIN RESEARCH, 1996, 3 (03) :171-171
[35]  
MORRISON DC, 1997, 4 INT C IMM CONS TRA, P1
[36]   Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro [J].
Nakano, M ;
Kirikae, T .
JOURNAL OF ENDOTOXIN RESEARCH, 1996, 3 (03) :195-200
[37]  
NEU HC, 1985, AM J MED, V79, P2
[38]   BACTENECIN, A LEUKOCYTIC ANTIMICROBIAL PEPTIDE, IS CYTOTOXIC TO NEURONAL AND GLIAL-CELLS [J].
RADERMACHER, SW ;
SCHOOP, VM ;
SCHLUESENER, HJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 36 (06) :657-662
[39]  
Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39
[40]  
SCHLUESENER HJ, 1993, J NEUROIMMUNOL, V47, P119